Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19

28 Nov 2021

Abstract excerpt

The COVID-19 crisis and the development of the first approved mRNA vaccine have highlighted the power of RNA-based therapeutic strategies for the development of new medicines. Aside from RNA-vaccines, antisense oligonucleotides (ASOs) represent a new and very promising class of RNA-targeted therapy. Few drugs have already received approval from the Food and Drug Administration. Here, we underscored why and how...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA and protein synthesis mechanisms
Share to RNA Interference and Gene Delivery
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34842345
DOI: 10.1002/wrna.1703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19PMID 34842345Read ↗

Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug DevelopmentSemantic proximity Read ↗

Antisense Oligonucleotide-Based Therapy of Viral InfectionsSemantic proximity Read ↗

Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic FrontiersSemantic proximity Read ↗

<strong>Think Different with RNA Therapy: Can Antisense Oligonucleotides Be Used to Inhibit Replication and Transcription of SARS-Cov-2?</strong>Semantic proximity Read ↗

Development and application of ribonucleic acid therapy strategies against COVID-19Semantic proximity Read ↗

The Versatile Applications of Antisense Oligonucleotides in Modern MedicineSemantic proximity Read ↗

Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSVSemantic proximity Read ↗

Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A reviewSemantic proximity Read ↗

A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense TherapySemantic proximity Read ↗

Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development TherapeuticsSemantic proximity Read ↗

RNA interference as a promising treatment against SARS-CoV-2Semantic proximity Read ↗

Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.